Pharmacologic Approaches to Diabetes Treatment: Oral Medications
Monograph
Are you a Pharmacist? Check out the Pharmacist version of this course.
Course Summary
The management of Type 2 diabetes mellitus (T2DM) involves a holistic, patient-centered approach that encompasses lifestyle modifications and the use of pharmacologic therapies. While current American Diabetes Association (ADA) Standards of Care 2023 guidelines highlight the benefits of injectable agents for reaching glycemic and weight loss goals and reducing cardiorenal risks, oral antidiabetic (OAD) medications still have important roles to play in the care plans of many patients. Numerous classes of OADs are available, each with its unique mechanism of action, efficacy, and safety profile. This course will compare available oral medications for diabetes with a discussion of mechanisms of action, dosing, side effects, and contraindications. The suggested place of these various medications within a therapeutic regimen will be discussed in the context of the updated American Diabetes Association Standards of Care in Diabetes 2023 guidelines.
Course Objectives
Compare and contrast the mechanisms of action of available oral diabetes medications
Describe the side effects and contraindications of oral diabetes medications
Identify when to utilize oral diabetes medications within a therapeutic regimen for patients with Type 2 diabetes mellitus
Recall patient counseling points related to the use of oral diabetes medications
I. Introduction
II. Oral Antidiabetic Medications
1. Metformin
2. Sulfonylureas
3. Thiazolidinediones
4. DPP4-Inhibitors
5. SGLT-2 Inhibitors
6. Other Oral Agents
III. Choice of Glucose-Lowering Therapy
1. Combination Therapy
2. Glycemic Control
3. Weight Effects
4. Hypoglycemia
5. Cardiovascular and Renal Protection
6. Cost
IV. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The management of Type 2 diabetes mellitus (T2DM) involves a holistic, patient-centered approach that encompasses lifestyle modifications and the use of pharmacologic therapies. While current American Diabetes Association (ADA) Standards of Care 2023 guidelines highlight the benefits of injectable agents for reaching glycemic and weight loss goals and reducing cardiorenal risks, oral antidiabetic (OAD) medications still have important roles to play in the care plans of many patients. Numerous classes of OADs are available, each with its unique mechanism of action, efficacy, and safety profile. This course will compare available oral medications for diabetes with a discussion of mechanisms of action, dosing, side effects, and contraindications. The suggested place of these various medications within a therapeutic regimen will be discussed in the context of the updated American Diabetes Association Standards of Care in Diabetes 2023 guidelines.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
Rating: 4.95/5
Based on the ratings of 61 customers
- Target Audience: Pharmacy Tech
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 6/24/2023
- Activity Expiration Date: 6/24/2026
- Activity Type: Knowledge
- UAN: 0669-0000-23-097-H01-T
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-944507
Author:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".